Reports

- Global Locations -

Headquarters

Future Market Insights, Inc.

Christiana Corporate, 200
Continental Drive, Suite 401,
Newark, Delaware - 19713,
United States

T: +1-845-579-5705

Americas

Future Market Insights, Inc.

616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989, United States

T: +1-347-918-3531

MEA

Future Market Insights

1602-6 Jumeirah Bay X2 Tower, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates

Europe

Future Market Insights

3rd Floor, 207 Regent Street,
W1B 3HH London
United Kingdom

T: + 44 (0) 20 8123 9659
D: +44 (0) 20 3287 4268

Asia Pacific

Future Market Insights

IndiaLand Global Tech Park, Unit UG-1, Behind Grand HighStreet, Phase 1, Hinjawadi, MH, Pune – 411057, India

Bone Marrow Transplant Market Outlook

The bone marrow transplant market is anticipated to flourish at an average CAGR of 3.4% between 2023 and 2033. The market is expected to hold a market share of US$ 14.86 billion by 2033, while the market is likely to reach a value of US$ 10.65 billion in 2023. A historical CAGR of 2.5% has been recorded by the experts of Future Market Insights for the market concerned.

The hematopoietic stem cell is a soft vascular tissue in the interiors of long bones, and a bone marrow transplant is identified as the procedure to replace the damaged or destroyed bone marrow with healthy bone marrow stem cells.

Attributes Details
Bone Marrow Transplant Market CAGR (2023 to 2033) 3.4%
Bone Marrow Transplant Market Size (2023) US$ 10.65 billion
Bone Marrow Transplant Market Size (2033) US$ 14.86 billion

The bone marrow transplant procedure is prescribed for the treatment of advanced stages of leukemia, Hodgkin, and non-Hodgkin lymphomas, multiple myeloma, aplastic and sickle cell anemia, thalassemia, and other diseases. Increasing awareness, combined with an increase in initiatives run by healthcare practitioners, is majorly responsible for the global growth of the market.

Don't pay for what you don't need

Customize your report by selecting specific countries or regions and save 30%!

Market Scenario Analysis Potential Drivers and Restraints

The market is anticipated to have mixed dynamics contributing to the bearish propulsion of the bone marrow transplant market. Several factors impacting the expansion of the market are identified during the study.

Besides the factors influencing growth, it is also identified that certain aspects can limit growth and curb the pace of growth further in the market.

Drivers:

  • The key factor affecting the bone marrow transplant industry is the surge in the prevalence of blood cancer and other blood-related diseases. The statistics predicted by the experts of FMI are anticipated to help the forum propel over the forecast period.
  • The growing incidences of non-Hodgkin and Hodgkin lymphoma, thalassemia, and leukemia, along with the common bone marrow diseases around the world, the developments in technology, and the enhancement of the healthcare infrastructure are likely to drive the market in the long run.
  • A steep increase in the development of stem cell cryopreservation, identified as the need of the hour, is majorly contributing to the bone marrow transplant market and is likely to gain further traction in the upcoming years.
  • An increase in research and development activities is projected to boost the market, and new products are being launched that may help the industry flourish over the forecast period.
  • A rise in funding for logistic services and growing per capita healthcare expenses are expected to propel the market's growth.

Restraints:

  • It is identified that there is a high expenditure associated with the treatment, and the high cost of bone marrow transplant is likely to serve as a deterring factor for the bone marrow transplant market, as a large section of the populace cannot afford such expensive treatment of the diseases.
  • There is a shortage of bone marrow donors, which is an aspect responsible for the impeding growth of the bone marrow transplant market in the near future.
  • The lack of reimbursement policies for organ transplantation procedures in emerging economies and developed countries is expected to hamper the growth of the industry during the period.

Country-wise Insights

Country Revenue Share % (2022)
United States 30.3%
Germany 11.9%
Japan 2/0%
North America 32.3%
Europe 53.1%
Country CAGR % (2023 to 2033)
China 4.2%
India 3.4%
United Kingdom 2.4%
Australia 3.1%

Overview of the North America Bone Marrow Transplant Market

North America is projected to secure steady bone marrow transplant market growth during the forecast period. The region cumulatively held 32.3% market share of the global bone marrow transplant market in 2022.

The factors attributing to the growth can be mentioned as follows:

  • There is a growth in the healthcare infrastructure of North America; capital expenditures are initiated by the key players prevailing in this region, coupled with an installed base for different kinds of products for the bone marrow transplant market.
  • It is anticipated that the North American region is having favorable regulatory scenarios that are likely to impact the bone marrow transplant market positively.

European Region Bolstering the Global Bone Marrow Transplant Market

Europe is projected to dominate the global market for bone marrow transplants during the forecast period. At present, Europe holds 53.1% of the total market share for bone marrow transplants worldwide in 2022.

The reasons owing for such extensive market expansion are mentioned below:

  • The increasing geriatric population of Europe is widely driving the bone marrow transplant market as they are more prone to severe diseases.
  • The innovative healthcare systems have introduced bone marrow transplants in their contributions and the state-of-the-art public facilities, which may further boost the growth of the bone marrow transplant market in the region during the forecast period.
  • New technology penetration in Europe is another factor boosting the concerned market of the region.
Sabyasachi Ghosh
Sabyasachi Ghosh

Principal Consultant

Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Categorical Analysis

Category By Transplant Type
Leading Segment Autologous
Market Share (2022) 54.5%
Category By End User
Leading Segment Hospital
Market Share (2022) 90.3%

Start-up Ecosystem

The start-ups in the bone marrow transplant market are indulging in collaborations and continually making innovations to stem cell transplant procedures to further make it convenient and cost-efficient for the population.

Company Name Magenta Therapeutics, Cambridge (United States)
Total Funding US$ 151 million
Description Developed stem cell-based therapies for autoimmune disease, genetic blood disorders, and cancer. The company has developed stem cell transplants by using targeted antibodies, stem cell harvesting using new biologic agents, and increasing stem cell numbers by targeting self-renewal pathways.
Company Name Kiadis Pharma, Amsterdam (Netherlands)
Total Funding US$ 33 million
Description Kiadis Pharma is a developer of therapeutic solutions for hematopoietic stem cell transplants. It is focused on developing solutions for complications and limitations of hematopoietic stem cell transplants (HSCT) in blood cancer patients. The company uses all depleted T-cell immunotherapeutics (ATIR) to support the patient’s newly transplanted immune system before it becomes fully functional. This enables better acceptance of even haploidentical (or lower) stem cell donors. Kiadis is investigating the use of ATIR in leukemia and thalassemia.
Company Name Talaris, Boston
Total Funding US$ 215 million
Description Talaris Therapeutics is involved in developing single-dose cell therapy to treat living donor kidney transplant tolerance. They have developed a proprietary technology that allows candidates for bone marrow transplants to receive hematopoietic stem cells (HSCs). The lead candidate, FCR001, is in phase III clinical trial, which is being investigated for living donor kidney transplant tolerance.

Get the data you need at a Fraction of the cost

Personalize your report by choosing insights you need
and save 40%!

Competitive Landscape

The bone marrow transplant market is highly competitive and consists of several leading players. To increase their global market presence, market leaders are engaging in various product launches, mergers and acquisitions, and development activities focusing on orthopedic surgical treatments.

Recent Developments

Some Recent Developments Identified in the Analysis are:

  • In May 2020, Gamida Cell Ltd., an advanced cell therapy company committed to finding cures for blood cancer and serious blood diseases, declared positive topline results from its Phase 3 clinical study evaluating the safety and efficacy of omidubicel, investigational advanced cell therapy in development as a potentially life-saving treatment option for patients in need of bone marrow transplant.
  • In November 2019, Lonza Group Ltd. partnered with Cryoport, Inc. in the cell and gene therapy field and across Lonza's 'vein-to-vein' delivery network.
  • In September 2017, Inotek Pharmaceuticals entered into a definitive merger agreement with Rocket Pharmaceuticals, a United States-based gene therapy company.

Key Players

  • Merck Millipore Corporation
  • Sanofi-Aventis LLC.
  • AllCells LLC.
  • STEMCELL Technologies
  • ATCC Inc.
  • Hemacare Corporation
  • Cellular Dynamics International
  • ReachBio LLC.
  • Conversant Bio ABM Inc.
  • PromoCell GmbH
  • Cruline Human biospecimen PRO
  • Lifeline Cell Technology
  • Mesoblast Ltd.

Key Segments Covered

By Transplant Type:

  • Autologous
  • Allogeneic

By Disease Indication:

  • Leukemia
  • Lymphoma
  • Myeloma
  • Others (anemia, thalassemia, etc.)

By End User:

  • Hospitals
  • Multispecialty Clinics
  • Ambulatory Surgical Centers
  • Others

Key Regions Covered:

  • North America
    • United States
    • Canada
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Europe
    • Germany
    • United Kingdom
    • France
    • Spain
    • Russia
    • Rest of Europe
  • Japan
  • Asia Pacific Excluding Japan
    • China
    • India
    • Malaysia
    • Singapore
    • Australia
    • Rest of Asia Pacific Excluding Japan (APEJ)
  • The Middle East and Africa
    • GCC Countries
    • Israel
    • South Africa
    • Middle East and Africa (MEA)

Frequently Asked Questions

How Significant Is the Current Market?

The market is anticipated to be valued at US$ 10.65 billion in 2023.

How Has the Market Developed in The Past?

The global market advanced at a 2.5% HCAGR from 2018 to 2022.

What Is the Projected Market Growth Between 2023 And 2033?

Up until 2033, the market is anticipated to thrive at a CAGR of 3.4%.

How Much of The Market Is Accounted for By the United States?

Potentially holding 32.3% of the market in North America.

What is The Market Share of Europe?

The market has been dominated by Europe, 53.1%.

What Will the Market Be Worth In 2033?

By 2033, the market is anticipated to be worth US$14.86 billion.

What Is the Prominent Transplant Type on The Market?

The autologous category to escalate to a market share of 54.5% in 2023.

Table of Content

1. Executive Summary

    1.1. Global Market Outlook

    1.2. Demand-side Trends

    1.3. Supply-side Trends

    1.4. Technology Roadmap Analysis

    1.5. Analysis and Recommendations

2. Market Overview

    2.1. Market Coverage / Taxonomy

    2.2. Market Definition / Scope / Limitations

3. Market Background

    3.1. Market Dynamics

        3.1.1. Drivers

        3.1.2. Restraints

        3.1.3. Opportunity

        3.1.4. Trends

    3.2. Scenario Forecast

        3.2.1. Demand in Optimistic Scenario

        3.2.2. Demand in Likely Scenario

        3.2.3. Demand in Conservative Scenario

    3.3. Opportunity Map Analysis

    3.4. Investment Feasibility Matrix

    3.5. PESTLE and Porter’s Analysis

    3.6. Regulatory Landscape

        3.6.1. By Key Regions

        3.6.2. By Key Countries

    3.7. Regional Parent Market Outlook

4. Global Market Analysis 2018 to 2022 and Forecast, 2023 to 2033

    4.1. Historical Market Size Value (US$ Million) Analysis, 2018 to 2022

    4.2. Current and Future Market Size Value (US$ Million) Projections, 2023 to 2033

        4.2.1. Y-o-Y Growth Trend Analysis

        4.2.2. Absolute $ Opportunity Analysis

5. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Transplant Type

    5.1. Introduction / Key Findings

    5.2. Historical Market Size Value (US$ Million) Analysis By Transplant Type, 2018 to 2022

    5.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Transplant Type, 2023 to 2033

        5.3.1. Autologous

        5.3.2. Allogeneic

    5.4. Y-o-Y Growth Trend Analysis By Transplant Type, 2018 to 2022

    5.5. Absolute $ Opportunity Analysis By Transplant Type, 2023 to 2033

6. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Disease Indication

    6.1. Introduction / Key Findings

    6.2. Historical Market Size Value (US$ Million) Analysis By Disease Indication, 2018 to 2022

    6.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Disease Indication, 2023 to 2033

        6.3.1. Leukemia

        6.3.2. Lymphoma

        6.3.3. Myeloma

        6.3.4. Others

    6.4. Y-o-Y Growth Trend Analysis By Disease Indication, 2018 to 2022

    6.5. Absolute $ Opportunity Analysis By Disease Indication, 2023 to 2033

7. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By End-User

    7.1. Introduction / Key Findings

    7.2. Historical Market Size Value (US$ Million) Analysis By End-User , 2018 to 2022

    7.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By End-User , 2023 to 2033

        7.3.1. Hospitals

        7.3.2. Multispecialty Clinics

        7.3.3. Ambulatory Surgical Centers

        7.3.4. Others

    7.4. Y-o-Y Growth Trend Analysis By End-User , 2018 to 2022

    7.5. Absolute $ Opportunity Analysis By End-User , 2023 to 2033

8. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Region

    8.1. Introduction

    8.2. Historical Market Size Value (US$ Million) Analysis By Region, 2018 to 2022

    8.3. Current Market Size Value (US$ Million) Analysis and Forecast By Region, 2023 to 2033

        8.3.1. North America

        8.3.2. Latin America

        8.3.3. Western Europe

        8.3.4. Eastern Europe

        8.3.5. South Asia and Pacific

        8.3.6. East Asia

        8.3.7. Middle East and Africa

    8.4. Market Attractiveness Analysis By Region

9. North America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    9.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022

    9.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033

        9.2.1. By Country

            9.2.1.1. USA.

            9.2.1.2. Canada

        9.2.2. By Transplant Type

        9.2.3. By Disease Indication

        9.2.4. By End-User

    9.3. Market Attractiveness Analysis

        9.3.1. By Country

        9.3.2. By Transplant Type

        9.3.3. By Disease Indication

        9.3.4. By End-User

    9.4. Key Takeaways

10. Latin America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    10.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022

    10.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033

        10.2.1. By Country

            10.2.1.1. Brazil

            10.2.1.2. Mexico

            10.2.1.3. Rest of Latin America

        10.2.2. By Transplant Type

        10.2.3. By Disease Indication

        10.2.4. By End-User

    10.3. Market Attractiveness Analysis

        10.3.1. By Country

        10.3.2. By Transplant Type

        10.3.3. By Disease Indication

        10.3.4. By End-User

    10.4. Key Takeaways

11. Western Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    11.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022

    11.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033

        11.2.1. By Country

            11.2.1.1. Germany

            11.2.1.2. United Kingdom.

            11.2.1.3. France

            11.2.1.4. Spain

            11.2.1.5. Italy

            11.2.1.6. Rest of Western Europe

        11.2.2. By Transplant Type

        11.2.3. By Disease Indication

        11.2.4. By End-User

    11.3. Market Attractiveness Analysis

        11.3.1. By Country

        11.3.2. By Transplant Type

        11.3.3. By Disease Indication

        11.3.4. By End-User

    11.4. Key Takeaways

12. Eastern Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    12.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022

    12.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033

        12.2.1. By Country

            12.2.1.1. Poland

            12.2.1.2. Russia

            12.2.1.3. Czech Republic

            12.2.1.4. Romania

            12.2.1.5. Rest of Eastern Europe

        12.2.2. By Transplant Type

        12.2.3. By Disease Indication

        12.2.4. By End-User

    12.3. Market Attractiveness Analysis

        12.3.1. By Country

        12.3.2. By Transplant Type

        12.3.3. By Disease Indication

        12.3.4. By End-User

    12.4. Key Takeaways

13. South Asia and Pacific Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    13.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022

    13.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033

        13.2.1. By Country

            13.2.1.1. India

            13.2.1.2. Bangladesh

            13.2.1.3. Australia

            13.2.1.4. New Zealand

            13.2.1.5. Rest of South Asia and Pacific

        13.2.2. By Transplant Type

        13.2.3. By Disease Indication

        13.2.4. By End-User

    13.3. Market Attractiveness Analysis

        13.3.1. By Country

        13.3.2. By Transplant Type

        13.3.3. By Disease Indication

        13.3.4. By End-User

    13.4. Key Takeaways

14. East Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    14.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022

    14.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033

        14.2.1. By Country

            14.2.1.1. China

            14.2.1.2. Japan

            14.2.1.3. South Korea

        14.2.2. By Transplant Type

        14.2.3. By Disease Indication

        14.2.4. By End-User

    14.3. Market Attractiveness Analysis

        14.3.1. By Country

        14.3.2. By Transplant Type

        14.3.3. By Disease Indication

        14.3.4. By End-User

    14.4. Key Takeaways

15. Middle East and Africa Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    15.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022

    15.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033

        15.2.1. By Country

            15.2.1.1. GCC Countries

            15.2.1.2. South Africa

            15.2.1.3. Israel

            15.2.1.4. Rest of MEA

        15.2.2. By Transplant Type

        15.2.3. By Disease Indication

        15.2.4. By End-User

    15.3. Market Attractiveness Analysis

        15.3.1. By Country

        15.3.2. By Transplant Type

        15.3.3. By Disease Indication

        15.3.4. By End-User

    15.4. Key Takeaways

16. Key Countries Market Analysis

    16.1. USA.

        16.1.1. Pricing Analysis

        16.1.2. Market Share Analysis, 2022

            16.1.2.1. By Transplant Type

            16.1.2.2. By Disease Indication

            16.1.2.3. By End-User

    16.2. Canada

        16.2.1. Pricing Analysis

        16.2.2. Market Share Analysis, 2022

            16.2.2.1. By Transplant Type

            16.2.2.2. By Disease Indication

            16.2.2.3. By End-User

    16.3. Brazil

        16.3.1. Pricing Analysis

        16.3.2. Market Share Analysis, 2022

            16.3.2.1. By Transplant Type

            16.3.2.2. By Disease Indication

            16.3.2.3. By End-User

    16.4. Mexico

        16.4.1. Pricing Analysis

        16.4.2. Market Share Analysis, 2022

            16.4.2.1. By Transplant Type

            16.4.2.2. By Disease Indication

            16.4.2.3. By End-User

    16.5. Germany

        16.5.1. Pricing Analysis

        16.5.2. Market Share Analysis, 2022

            16.5.2.1. By Transplant Type

            16.5.2.2. By Disease Indication

            16.5.2.3. By End-User

    16.6. United Kingdom.

        16.6.1. Pricing Analysis

        16.6.2. Market Share Analysis, 2022

            16.6.2.1. By Transplant Type

            16.6.2.2. By Disease Indication

            16.6.2.3. By End-User

    16.7. France

        16.7.1. Pricing Analysis

        16.7.2. Market Share Analysis, 2022

            16.7.2.1. By Transplant Type

            16.7.2.2. By Disease Indication

            16.7.2.3. By End-User

    16.8. Spain

        16.8.1. Pricing Analysis

        16.8.2. Market Share Analysis, 2022

            16.8.2.1. By Transplant Type

            16.8.2.2. By Disease Indication

            16.8.2.3. By End-User

    16.9. Italy

        16.9.1. Pricing Analysis

        16.9.2. Market Share Analysis, 2022

            16.9.2.1. By Transplant Type

            16.9.2.2. By Disease Indication

            16.9.2.3. By End-User

    16.10. Poland

        16.10.1. Pricing Analysis

        16.10.2. Market Share Analysis, 2022

            16.10.2.1. By Transplant Type

            16.10.2.2. By Disease Indication

            16.10.2.3. By End-User

    16.11. Russia

        16.11.1. Pricing Analysis

        16.11.2. Market Share Analysis, 2022

            16.11.2.1. By Transplant Type

            16.11.2.2. By Disease Indication

            16.11.2.3. By End-User

    16.12. Czech Republic

        16.12.1. Pricing Analysis

        16.12.2. Market Share Analysis, 2022

            16.12.2.1. By Transplant Type

            16.12.2.2. By Disease Indication

            16.12.2.3. By End-User

    16.13. Romania

        16.13.1. Pricing Analysis

        16.13.2. Market Share Analysis, 2022

            16.13.2.1. By Transplant Type

            16.13.2.2. By Disease Indication

            16.13.2.3. By End-User

    16.14. India

        16.14.1. Pricing Analysis

        16.14.2. Market Share Analysis, 2022

            16.14.2.1. By Transplant Type

            16.14.2.2. By Disease Indication

            16.14.2.3. By End-User

    16.15. Bangladesh

        16.15.1. Pricing Analysis

        16.15.2. Market Share Analysis, 2022

            16.15.2.1. By Transplant Type

            16.15.2.2. By Disease Indication

            16.15.2.3. By End-User

    16.16. Australia

        16.16.1. Pricing Analysis

        16.16.2. Market Share Analysis, 2022

            16.16.2.1. By Transplant Type

            16.16.2.2. By Disease Indication

            16.16.2.3. By End-User

    16.17. New Zealand

        16.17.1. Pricing Analysis

        16.17.2. Market Share Analysis, 2022

            16.17.2.1. By Transplant Type

            16.17.2.2. By Disease Indication

            16.17.2.3. By End-User

    16.18. China

        16.18.1. Pricing Analysis

        16.18.2. Market Share Analysis, 2022

            16.18.2.1. By Transplant Type

            16.18.2.2. By Disease Indication

            16.18.2.3. By End-User

    16.19. Japan

        16.19.1. Pricing Analysis

        16.19.2. Market Share Analysis, 2022

            16.19.2.1. By Transplant Type

            16.19.2.2. By Disease Indication

            16.19.2.3. By End-User

    16.20. South Korea

        16.20.1. Pricing Analysis

        16.20.2. Market Share Analysis, 2022

            16.20.2.1. By Transplant Type

            16.20.2.2. By Disease Indication

            16.20.2.3. By End-User

    16.21. GCC Countries

        16.21.1. Pricing Analysis

        16.21.2. Market Share Analysis, 2022

            16.21.2.1. By Transplant Type

            16.21.2.2. By Disease Indication

            16.21.2.3. By End-User

    16.22. South Africa

        16.22.1. Pricing Analysis

        16.22.2. Market Share Analysis, 2022

            16.22.2.1. By Transplant Type

            16.22.2.2. By Disease Indication

            16.22.2.3. By End-User

    16.23. Israel

        16.23.1. Pricing Analysis

        16.23.2. Market Share Analysis, 2022

            16.23.2.1. By Transplant Type

            16.23.2.2. By Disease Indication

            16.23.2.3. By End-User

17. Market Structure Analysis

    17.1. Competition Dashboard

    17.2. Competition Benchmarking

    17.3. Market Share Analysis of Top Players

        17.3.1. By Regional

        17.3.2. By Transplant Type

        17.3.3. By Disease Indication

        17.3.4. By End-User

18. Competition Analysis

    18.1. Competition Deep Dive

        18.1.1. Lonza Group Ltd.

            18.1.1.1. Overview

            18.1.1.2. Product Portfolio

            18.1.1.3. Profitability by Market Segments

            18.1.1.4. Sales Footprint

            18.1.1.5. Strategy Overview

                18.1.1.5.1. Marketing Strategy

        18.1.2. Merck Millipore Corporation

            18.1.2.1. Overview

            18.1.2.2. Product Portfolio

            18.1.2.3. Profitability by Market Segments

            18.1.2.4. Sales Footprint

            18.1.2.5. Strategy Overview

                18.1.2.5.1. Marketing Strategy

        18.1.3. Sanofi-Aventis LLC.

            18.1.3.1. Overview

            18.1.3.2. Product Portfolio

            18.1.3.3. Profitability by Market Segments

            18.1.3.4. Sales Footprint

            18.1.3.5. Strategy Overview

                18.1.3.5.1. Marketing Strategy

        18.1.4. AllCells LLC.

            18.1.4.1. Overview

            18.1.4.2. Product Portfolio

            18.1.4.3. Profitability by Market Segments

            18.1.4.4. Sales Footprint

            18.1.4.5. Strategy Overview

                18.1.4.5.1. Marketing Strategy

        18.1.5. STEMCELL Technologies

            18.1.5.1. Overview

            18.1.5.2. Product Portfolio

            18.1.5.3. Profitability by Market Segments

            18.1.5.4. Sales Footprint

            18.1.5.5. Strategy Overview

                18.1.5.5.1. Marketing Strategy

        18.1.6. ATCC Inc.

            18.1.6.1. Overview

            18.1.6.2. Product Portfolio

            18.1.6.3. Profitability by Market Segments

            18.1.6.4. Sales Footprint

            18.1.6.5. Strategy Overview

                18.1.6.5.1. Marketing Strategy

        18.1.7. Hemacare Corporation

            18.1.7.1. Overview

            18.1.7.2. Product Portfolio

            18.1.7.3. Profitability by Market Segments

            18.1.7.4. Sales Footprint

            18.1.7.5. Strategy Overview

                18.1.7.5.1. Marketing Strategy

        18.1.8. Cellular Dynamics International

            18.1.8.1. Overview

            18.1.8.2. Product Portfolio

            18.1.8.3. Profitability by Market Segments

            18.1.8.4. Sales Footprint

            18.1.8.5. Strategy Overview

                18.1.8.5.1. Marketing Strategy

        18.1.9. ReachBio LLC.

            18.1.9.1. Overview

            18.1.9.2. Product Portfolio

            18.1.9.3. Profitability by Market Segments

            18.1.9.4. Sales Footprint

            18.1.9.5. Strategy Overview

                18.1.9.5.1. Marketing Strategy

        18.1.10. Conversant Bio, ABM Inc.

            18.1.10.1. Overview

            18.1.10.2. Product Portfolio

            18.1.10.3. Profitability by Market Segments

            18.1.10.4. Sales Footprint

            18.1.10.5. Strategy Overview

                18.1.10.5.1. Marketing Strategy

        18.1.11. PromoCell GmbH

            18.1.11.1. Overview

            18.1.11.2. Product Portfolio

            18.1.11.3. Profitability by Market Segments

            18.1.11.4. Sales Footprint

            18.1.11.5. Strategy Overview

                18.1.11.5.1. Marketing Strategy

        18.1.12. Cruline Human biospecimen PRO

            18.1.12.1. Overview

            18.1.12.2. Product Portfolio

            18.1.12.3. Profitability by Market Segments

            18.1.12.4. Sales Footprint

            18.1.12.5. Strategy Overview

                18.1.12.5.1. Marketing Strategy

        18.1.13. Lifeline Cell Technology

            18.1.13.1. Overview

            18.1.13.2. Product Portfolio

            18.1.13.3. Profitability by Market Segments

            18.1.13.4. Sales Footprint

            18.1.13.5. Strategy Overview

                18.1.13.5.1. Marketing Strategy

        18.1.14. Mesoblast Ltd.

            18.1.14.1. Overview

            18.1.14.2. Product Portfolio

            18.1.14.3. Profitability by Market Segments

            18.1.14.4. Sales Footprint

            18.1.14.5. Strategy Overview

                18.1.14.5.1. Marketing Strategy

19. Assumptions & Acronyms Used

20. Research Methodology

Don't pay for what you don't need

Customize your report by selecting specific countries or regions and save 30%!

List of Tables

Table 1: Global Market Value (US$ Million) Forecast by Region, 2018 to 2033

Table 2: Global Market Value (US$ Million) Forecast by Transplant Type, 2018 to 2033

Table 3: Global Market Value (US$ Million) Forecast by Disease Indication, 2018 to 2033

Table 4: Global Market Value (US$ Million) Forecast by End-User , 2018 to 2033

Table 5: North America Market Value (US$ Million) Forecast by Country, 2018 to 2033

Table 6: North America Market Value (US$ Million) Forecast by Transplant Type, 2018 to 2033

Table 7: North America Market Value (US$ Million) Forecast by Disease Indication, 2018 to 2033

Table 8: North America Market Value (US$ Million) Forecast by End-User , 2018 to 2033

Table 9: Latin America Market Value (US$ Million) Forecast by Country, 2018 to 2033

Table 10: Latin America Market Value (US$ Million) Forecast by Transplant Type, 2018 to 2033

Table 11: Latin America Market Value (US$ Million) Forecast by Disease Indication, 2018 to 2033

Table 12: Latin America Market Value (US$ Million) Forecast by End-User , 2018 to 2033

Table 13: Western Europe Market Value (US$ Million) Forecast by Country, 2018 to 2033

Table 14: Western Europe Market Value (US$ Million) Forecast by Transplant Type, 2018 to 2033

Table 15: Western Europe Market Value (US$ Million) Forecast by Disease Indication, 2018 to 2033

Table 16: Western Europe Market Value (US$ Million) Forecast by End-User , 2018 to 2033

Table 17: Eastern Europe Market Value (US$ Million) Forecast by Country, 2018 to 2033

Table 18: Eastern Europe Market Value (US$ Million) Forecast by Transplant Type, 2018 to 2033

Table 19: Eastern Europe Market Value (US$ Million) Forecast by Disease Indication, 2018 to 2033

Table 20: Eastern Europe Market Value (US$ Million) Forecast by End-User , 2018 to 2033

Table 21: South Asia and Pacific Market Value (US$ Million) Forecast by Country, 2018 to 2033

Table 22: South Asia and Pacific Market Value (US$ Million) Forecast by Transplant Type, 2018 to 2033

Table 23: South Asia and Pacific Market Value (US$ Million) Forecast by Disease Indication, 2018 to 2033

Table 24: South Asia and Pacific Market Value (US$ Million) Forecast by End-User , 2018 to 2033

Table 25: East Asia Market Value (US$ Million) Forecast by Country, 2018 to 2033

Table 26: East Asia Market Value (US$ Million) Forecast by Transplant Type, 2018 to 2033

Table 27: East Asia Market Value (US$ Million) Forecast by Disease Indication, 2018 to 2033

Table 28: East Asia Market Value (US$ Million) Forecast by End-User , 2018 to 2033

Table 29: Middle East and Africa Market Value (US$ Million) Forecast by Country, 2018 to 2033

Table 30: Middle East and Africa Market Value (US$ Million) Forecast by Transplant Type, 2018 to 2033

Table 31: Middle East and Africa Market Value (US$ Million) Forecast by Disease Indication, 2018 to 2033

Table 32: Middle East and Africa Market Value (US$ Million) Forecast by End-User , 2018 to 2033
Sabyasachi Ghosh
Sabyasachi Ghosh

Principal Consultant

Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

List of Charts

Figure 1: Global Market Value (US$ Million) by Transplant Type, 2023 to 2033

Figure 2: Global Market Value (US$ Million) by Disease Indication, 2023 to 2033

Figure 3: Global Market Value (US$ Million) by End-User , 2023 to 2033

Figure 4: Global Market Value (US$ Million) by Region, 2023 to 2033

Figure 5: Global Market Value (US$ Million) Analysis by Region, 2018 to 2033

Figure 6: Global Market Value Share (%) and BPS Analysis by Region, 2023 to 2033

Figure 7: Global Market Y-o-Y Growth (%) Projections by Region, 2023 to 2033

Figure 8: Global Market Value (US$ Million) Analysis by Transplant Type, 2018 to 2033

Figure 9: Global Market Value Share (%) and BPS Analysis by Transplant Type, 2023 to 2033

Figure 10: Global Market Y-o-Y Growth (%) Projections by Transplant Type, 2023 to 2033

Figure 11: Global Market Value (US$ Million) Analysis by Disease Indication, 2018 to 2033

Figure 12: Global Market Value Share (%) and BPS Analysis by Disease Indication, 2023 to 2033

Figure 13: Global Market Y-o-Y Growth (%) Projections by Disease Indication, 2023 to 2033

Figure 14: Global Market Value (US$ Million) Analysis by End-User , 2018 to 2033

Figure 15: Global Market Value Share (%) and BPS Analysis by End-User , 2023 to 2033

Figure 16: Global Market Y-o-Y Growth (%) Projections by End-User , 2023 to 2033

Figure 17: Global Market Attractiveness by Transplant Type, 2023 to 2033

Figure 18: Global Market Attractiveness by Disease Indication, 2023 to 2033

Figure 19: Global Market Attractiveness by End-User , 2023 to 2033

Figure 20: Global Market Attractiveness by Region, 2023 to 2033

Figure 21: North America Market Value (US$ Million) by Transplant Type, 2023 to 2033

Figure 22: North America Market Value (US$ Million) by Disease Indication, 2023 to 2033

Figure 23: North America Market Value (US$ Million) by End-User , 2023 to 2033

Figure 24: North America Market Value (US$ Million) by Country, 2023 to 2033

Figure 25: North America Market Value (US$ Million) Analysis by Country, 2018 to 2033

Figure 26: North America Market Value Share (%) and BPS Analysis by Country, 2023 to 2033

Figure 27: North America Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033

Figure 28: North America Market Value (US$ Million) Analysis by Transplant Type, 2018 to 2033

Figure 29: North America Market Value Share (%) and BPS Analysis by Transplant Type, 2023 to 2033

Figure 30: North America Market Y-o-Y Growth (%) Projections by Transplant Type, 2023 to 2033

Figure 31: North America Market Value (US$ Million) Analysis by Disease Indication, 2018 to 2033

Figure 32: North America Market Value Share (%) and BPS Analysis by Disease Indication, 2023 to 2033

Figure 33: North America Market Y-o-Y Growth (%) Projections by Disease Indication, 2023 to 2033

Figure 34: North America Market Value (US$ Million) Analysis by End-User , 2018 to 2033

Figure 35: North America Market Value Share (%) and BPS Analysis by End-User , 2023 to 2033

Figure 36: North America Market Y-o-Y Growth (%) Projections by End-User , 2023 to 2033

Figure 37: North America Market Attractiveness by Transplant Type, 2023 to 2033

Figure 38: North America Market Attractiveness by Disease Indication, 2023 to 2033

Figure 39: North America Market Attractiveness by End-User , 2023 to 2033

Figure 40: North America Market Attractiveness by Country, 2023 to 2033

Figure 41: Latin America Market Value (US$ Million) by Transplant Type, 2023 to 2033

Figure 42: Latin America Market Value (US$ Million) by Disease Indication, 2023 to 2033

Figure 43: Latin America Market Value (US$ Million) by End-User , 2023 to 2033

Figure 44: Latin America Market Value (US$ Million) by Country, 2023 to 2033

Figure 45: Latin America Market Value (US$ Million) Analysis by Country, 2018 to 2033

Figure 46: Latin America Market Value Share (%) and BPS Analysis by Country, 2023 to 2033

Figure 47: Latin America Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033

Figure 48: Latin America Market Value (US$ Million) Analysis by Transplant Type, 2018 to 2033

Figure 49: Latin America Market Value Share (%) and BPS Analysis by Transplant Type, 2023 to 2033

Figure 50: Latin America Market Y-o-Y Growth (%) Projections by Transplant Type, 2023 to 2033

Figure 51: Latin America Market Value (US$ Million) Analysis by Disease Indication, 2018 to 2033

Figure 52: Latin America Market Value Share (%) and BPS Analysis by Disease Indication, 2023 to 2033

Figure 53: Latin America Market Y-o-Y Growth (%) Projections by Disease Indication, 2023 to 2033

Figure 54: Latin America Market Value (US$ Million) Analysis by End-User , 2018 to 2033

Figure 55: Latin America Market Value Share (%) and BPS Analysis by End-User , 2023 to 2033

Figure 56: Latin America Market Y-o-Y Growth (%) Projections by End-User , 2023 to 2033

Figure 57: Latin America Market Attractiveness by Transplant Type, 2023 to 2033

Figure 58: Latin America Market Attractiveness by Disease Indication, 2023 to 2033

Figure 59: Latin America Market Attractiveness by End-User , 2023 to 2033

Figure 60: Latin America Market Attractiveness by Country, 2023 to 2033

Figure 61: Western Europe Market Value (US$ Million) by Transplant Type, 2023 to 2033

Figure 62: Western Europe Market Value (US$ Million) by Disease Indication, 2023 to 2033

Figure 63: Western Europe Market Value (US$ Million) by End-User , 2023 to 2033

Figure 64: Western Europe Market Value (US$ Million) by Country, 2023 to 2033

Figure 65: Western Europe Market Value (US$ Million) Analysis by Country, 2018 to 2033

Figure 66: Western Europe Market Value Share (%) and BPS Analysis by Country, 2023 to 2033

Figure 67: Western Europe Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033

Figure 68: Western Europe Market Value (US$ Million) Analysis by Transplant Type, 2018 to 2033

Figure 69: Western Europe Market Value Share (%) and BPS Analysis by Transplant Type, 2023 to 2033

Figure 70: Western Europe Market Y-o-Y Growth (%) Projections by Transplant Type, 2023 to 2033

Figure 71: Western Europe Market Value (US$ Million) Analysis by Disease Indication, 2018 to 2033

Figure 72: Western Europe Market Value Share (%) and BPS Analysis by Disease Indication, 2023 to 2033

Figure 73: Western Europe Market Y-o-Y Growth (%) Projections by Disease Indication, 2023 to 2033

Figure 74: Western Europe Market Value (US$ Million) Analysis by End-User , 2018 to 2033

Figure 75: Western Europe Market Value Share (%) and BPS Analysis by End-User , 2023 to 2033

Figure 76: Western Europe Market Y-o-Y Growth (%) Projections by End-User , 2023 to 2033

Figure 77: Western Europe Market Attractiveness by Transplant Type, 2023 to 2033

Figure 78: Western Europe Market Attractiveness by Disease Indication, 2023 to 2033

Figure 79: Western Europe Market Attractiveness by End-User , 2023 to 2033

Figure 80: Western Europe Market Attractiveness by Country, 2023 to 2033

Figure 81: Eastern Europe Market Value (US$ Million) by Transplant Type, 2023 to 2033

Figure 82: Eastern Europe Market Value (US$ Million) by Disease Indication, 2023 to 2033

Figure 83: Eastern Europe Market Value (US$ Million) by End-User , 2023 to 2033

Figure 84: Eastern Europe Market Value (US$ Million) by Country, 2023 to 2033

Figure 85: Eastern Europe Market Value (US$ Million) Analysis by Country, 2018 to 2033

Figure 86: Eastern Europe Market Value Share (%) and BPS Analysis by Country, 2023 to 2033

Figure 87: Eastern Europe Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033

Figure 88: Eastern Europe Market Value (US$ Million) Analysis by Transplant Type, 2018 to 2033

Figure 89: Eastern Europe Market Value Share (%) and BPS Analysis by Transplant Type, 2023 to 2033

Figure 90: Eastern Europe Market Y-o-Y Growth (%) Projections by Transplant Type, 2023 to 2033

Figure 91: Eastern Europe Market Value (US$ Million) Analysis by Disease Indication, 2018 to 2033

Figure 92: Eastern Europe Market Value Share (%) and BPS Analysis by Disease Indication, 2023 to 2033

Figure 93: Eastern Europe Market Y-o-Y Growth (%) Projections by Disease Indication, 2023 to 2033

Figure 94: Eastern Europe Market Value (US$ Million) Analysis by End-User , 2018 to 2033

Figure 95: Eastern Europe Market Value Share (%) and BPS Analysis by End-User , 2023 to 2033

Figure 96: Eastern Europe Market Y-o-Y Growth (%) Projections by End-User , 2023 to 2033

Figure 97: Eastern Europe Market Attractiveness by Transplant Type, 2023 to 2033

Figure 98: Eastern Europe Market Attractiveness by Disease Indication, 2023 to 2033

Figure 99: Eastern Europe Market Attractiveness by End-User , 2023 to 2033

Figure 100: Eastern Europe Market Attractiveness by Country, 2023 to 2033

Figure 101: South Asia and Pacific Market Value (US$ Million) by Transplant Type, 2023 to 2033

Figure 102: South Asia and Pacific Market Value (US$ Million) by Disease Indication, 2023 to 2033

Figure 103: South Asia and Pacific Market Value (US$ Million) by End-User , 2023 to 2033

Figure 104: South Asia and Pacific Market Value (US$ Million) by Country, 2023 to 2033

Figure 105: South Asia and Pacific Market Value (US$ Million) Analysis by Country, 2018 to 2033

Figure 106: South Asia and Pacific Market Value Share (%) and BPS Analysis by Country, 2023 to 2033

Figure 107: South Asia and Pacific Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033

Figure 108: South Asia and Pacific Market Value (US$ Million) Analysis by Transplant Type, 2018 to 2033

Figure 109: South Asia and Pacific Market Value Share (%) and BPS Analysis by Transplant Type, 2023 to 2033

Figure 110: South Asia and Pacific Market Y-o-Y Growth (%) Projections by Transplant Type, 2023 to 2033

Figure 111: South Asia and Pacific Market Value (US$ Million) Analysis by Disease Indication, 2018 to 2033

Figure 112: South Asia and Pacific Market Value Share (%) and BPS Analysis by Disease Indication, 2023 to 2033

Figure 113: South Asia and Pacific Market Y-o-Y Growth (%) Projections by Disease Indication, 2023 to 2033

Figure 114: South Asia and Pacific Market Value (US$ Million) Analysis by End-User , 2018 to 2033

Figure 115: South Asia and Pacific Market Value Share (%) and BPS Analysis by End-User , 2023 to 2033

Figure 116: South Asia and Pacific Market Y-o-Y Growth (%) Projections by End-User , 2023 to 2033

Figure 117: South Asia and Pacific Market Attractiveness by Transplant Type, 2023 to 2033

Figure 118: South Asia and Pacific Market Attractiveness by Disease Indication, 2023 to 2033

Figure 119: South Asia and Pacific Market Attractiveness by End-User , 2023 to 2033

Figure 120: South Asia and Pacific Market Attractiveness by Country, 2023 to 2033

Figure 121: East Asia Market Value (US$ Million) by Transplant Type, 2023 to 2033

Figure 122: East Asia Market Value (US$ Million) by Disease Indication, 2023 to 2033

Figure 123: East Asia Market Value (US$ Million) by End-User , 2023 to 2033

Figure 124: East Asia Market Value (US$ Million) by Country, 2023 to 2033

Figure 125: East Asia Market Value (US$ Million) Analysis by Country, 2018 to 2033

Figure 126: East Asia Market Value Share (%) and BPS Analysis by Country, 2023 to 2033

Figure 127: East Asia Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033

Figure 128: East Asia Market Value (US$ Million) Analysis by Transplant Type, 2018 to 2033

Figure 129: East Asia Market Value Share (%) and BPS Analysis by Transplant Type, 2023 to 2033

Figure 130: East Asia Market Y-o-Y Growth (%) Projections by Transplant Type, 2023 to 2033

Figure 131: East Asia Market Value (US$ Million) Analysis by Disease Indication, 2018 to 2033

Figure 132: East Asia Market Value Share (%) and BPS Analysis by Disease Indication, 2023 to 2033

Figure 133: East Asia Market Y-o-Y Growth (%) Projections by Disease Indication, 2023 to 2033

Figure 134: East Asia Market Value (US$ Million) Analysis by End-User , 2018 to 2033

Figure 135: East Asia Market Value Share (%) and BPS Analysis by End-User , 2023 to 2033

Figure 136: East Asia Market Y-o-Y Growth (%) Projections by End-User , 2023 to 2033

Figure 137: East Asia Market Attractiveness by Transplant Type, 2023 to 2033

Figure 138: East Asia Market Attractiveness by Disease Indication, 2023 to 2033

Figure 139: East Asia Market Attractiveness by End-User , 2023 to 2033

Figure 140: East Asia Market Attractiveness by Country, 2023 to 2033

Figure 141: Middle East and Africa Market Value (US$ Million) by Transplant Type, 2023 to 2033

Figure 142: Middle East and Africa Market Value (US$ Million) by Disease Indication, 2023 to 2033

Figure 143: Middle East and Africa Market Value (US$ Million) by End-User , 2023 to 2033

Figure 144: Middle East and Africa Market Value (US$ Million) by Country, 2023 to 2033

Figure 145: Middle East and Africa Market Value (US$ Million) Analysis by Country, 2018 to 2033

Figure 146: Middle East and Africa Market Value Share (%) and BPS Analysis by Country, 2023 to 2033

Figure 147: Middle East and Africa Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033

Figure 148: Middle East and Africa Market Value (US$ Million) Analysis by Transplant Type, 2018 to 2033

Figure 149: Middle East and Africa Market Value Share (%) and BPS Analysis by Transplant Type, 2023 to 2033

Figure 150: Middle East and Africa Market Y-o-Y Growth (%) Projections by Transplant Type, 2023 to 2033

Figure 151: Middle East and Africa Market Value (US$ Million) Analysis by Disease Indication, 2018 to 2033

Figure 152: Middle East and Africa Market Value Share (%) and BPS Analysis by Disease Indication, 2023 to 2033

Figure 153: Middle East and Africa Market Y-o-Y Growth (%) Projections by Disease Indication, 2023 to 2033

Figure 154: Middle East and Africa Market Value (US$ Million) Analysis by End-User , 2018 to 2033

Figure 155: Middle East and Africa Market Value Share (%) and BPS Analysis by End-User , 2023 to 2033

Figure 156: Middle East and Africa Market Y-o-Y Growth (%) Projections by End-User , 2023 to 2033

Figure 157: Middle East and Africa Market Attractiveness by Transplant Type, 2023 to 2033

Figure 158: Middle East and Africa Market Attractiveness by Disease Indication, 2023 to 2033

Figure 159: Middle East and Africa Market Attractiveness by End-User , 2023 to 2033

Figure 160: Middle East and Africa Market Attractiveness by Country, 2023 to 2033

Recommendations

Healthcare

Bone Grafts and Substitutes Market

Published : November 2022

Healthcare

Stem Cell Therapies Market

Published : June 2022

Explore Healthcare Insights

View Reports

Bone Marrow Transplant Market